Rephonic
Artwork for Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive Podcast
FDA
Eli Lilly
Novo Nordisk
Pfizer
Pharmaceutical Industry
Artificial Intelligence
Wegovy
Trumprx
GSK
Novartis
Abbvie
Johnson & Johnson
Astrazeneca
Moderna
Cell and Gene Therapy
Glp-1
Clinical Trials
Tylenol
Diabetes
Amgen

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

PublishesDailyEpisodes352Founded8 years ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for Pharmaceutical Executive

Latest Episodes

In today’s Pharmaceutical Executive Daily, the FDA extends its priority review of a subcutaneous formulation of Leqembi, industry analysts examine how upcoming GLP-1 patent expirations could reshape the drug delivery device market, and experts discus... more

In today's Pharmaceutical Executive Daily, Angelini Pharma announces a $4.1 billion agreement to acquire Catalyst Pharmaceuticals, Incyte presents 24-week results from the Phase III TRuE-AD4 trial of Opzelura, and Pharmaceutical Executive speaks with... more

Natalie de Graaf, from the API Innovation Center, discusses a recent whitepaper detailing areas where the generic drugs pipeline is under stress.

In today's Pharmaceutical Executive Daily, Bayer agrees to acquire Perfuse Therapeutics for up to $2.45 billion and Madrigal obtains an exclusive global license for a precision siRNA therapy targeting a key genetic driver of MASH, Zentalis Pharmaceut... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Natalie de Graaf
Vice President and General Manager for Data Analytics, AI Machine Learning at the API Innovation Center
API Innovation Center
Episode: Strengthening the Generic Drugs Supply Chain
Peter Harbin
Industry analyst/commentator providing critique of pharma sales targeting models
(mentioned speculative)
Episode: Pharmaceutical Executive Daily: BioNTech Reports 2026 First Quarter Results
Jeff Golfman
Founder and President of CEN123
CEN123
Episode: Pharmaceutical Executive Daily: FDA Approves Auvelity
Maher Masoud
CEO of MaxCyte
MaxCyte
Episode: Pharmaceutical Executive Daily: FDA Approves Caplyta for Adults with Schizophrenia
Michael Grosberg
Vice President of Product Management at Model N
Model N
Episode: Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning
Jesse Mendelson
Model N executive involved in pricing and policy discussions
Model N
Episode: Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning
Deepak Prakash
Vice President of Health Care at Identiv
Identiv
Episode: Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement
Matt Holms
Vice President of Commercial Patient Engagement and Recruitment at Citeline
Citeline
Episode: Pharmaceutical Executive Daily: FDA Issues Second CRL for Replimune's RP1 Melanoma Treatment
Mark Bagnall
CEO of Phenomix Sciences
Phenomix Sciences
Episode: Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer

Reviews

4.2 out of 5 stars from 30 ratings
  • A must listen

    A value-packed podcast in a tidy package! Every episode brings excellent perspectives from knowledgeable guests, with actionable leadership tips as the cherry on top. Don't miss it!

    Apple Podcasts
    5
    Arlie K
    United States5 years ago
  • Suggestion

    Hi! I really enjoy this podcast. You discuss great topics and interview knowledgeable people. Improving the sound quality would really make the listening experience much more enjoyable. There tends to be a muffled and unclear effect to the sound. Thanks!

    Apple Podcasts
    4
    pharmalova
    United States7 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Guests reliably bring knowledgeable, practical perspectives for industry professionals.
Sound quality improvements could enhance the listening experience.
Value-packed episodes with actionable leadership tips and strong guest expertise.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Strengthening the Generic Drugs Supply Chain
Q: How do you see the role of government and industry cooperating to reduce dependency on foreign sources?
Cooperation is essential: industry networks plus API Innovation Center insights to drive domestic manufacturing investments, plus aligning lists like FDA's essential medicines, ASPR, and DOD inventories to prioritize the most fragile items, in tandem with allied nations to build a resilient, diversified supply base.
Strengthening the Generic Drugs Supply Chain
Q: What can be done to improve the supply chain fragility from a practical standpoint?
We need to create a unified fragility index that scores drugs and groups by importance to hospitals, ASPR, and national security needs, then use real-time data to guide investment decisions—potentially reshoring with an emphasis on where fragility is highest and capacity exists, including cross-border collaborations.
Strengthening the Generic Drugs Supply Chain
Q: So first, could you give a brief rundown of what your early release report found and what it implies for investment priorities?
The early findings show that anti-infectives are among the most vulnerable drug classes, signaling where investments should be prioritized. We're expanding the study to cover 3,000 APIs and downstream products, with a fragility score system to identify the most at-risk drugs and hospital/health system needs.
Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning
Q: What role does data play in solving GTN challenges?
Having all relevant prescription data in a single system enables accurate rebate evaluation, deduplication, and the ability to make informed, timely decisions; without it, coordination of benefits remains a significant hurdle.
Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning
Q: How are manufacturers viewing Medicaid participation in light of regulatory complexity?
More than a third are considering withdrawing from Medicaid due to onerous requirements, which would force a shift in how patient access is managed and potentially change the economics of rebates and access programs.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Pharmaceutical Executive

What is Pharmaceutical Executive about and what kind of topics does it cover?

A brisk, business-focused show that treats pharma and life sciences topics through executive-level conversations. Episodes emphasize market moves, regulatory milestones, pricing and GTN dynamics, and the operational realities of commercializing advanced therapies. Listeners can expect hard-hitting analyses of deals, policy shifts, and supply-chain considerations, with actionable takeaways for strategy, partnerships, and investment. A notable strength is bringing operator-level perspectives on scaling complex therapies and navigating global manufacturing and distribution, making it useful for leaders, investors, and partners evaluating opportunities in biotech and pharma.

Where can I find podcast stats for Pharmaceutical Executive?

Rephonic provides a wide range of podcast stats for Pharmaceutical Executive. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Pharmaceutical Executive and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Pharmaceutical Executive get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Pharmaceutical Executive, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Pharmaceutical Executive?

Rephonic provides comprehensive predictive audience data for Pharmaceutical Executive, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Pharmaceutical Executive have?

To see how many followers or subscribers Pharmaceutical Executive has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Pharmaceutical Executive?

These podcasts share a similar audience with Pharmaceutical Executive:

1. The Readout Loud
2. BioCentury This Week
3. In Good Company with Nicolai Tangen
4. Bloomberg Intelligence
5. Bloomberg Surveillance

How many episodes of Pharmaceutical Executive are there?

Pharmaceutical Executive launched 8 years ago and published 352 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Pharmaceutical Executive?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Pharmaceutical Executive?

Rephonic pulls ratings and reviews for Pharmaceutical Executive from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Pharmaceutical Executive?

Rephonic provides full transcripts for episodes of Pharmaceutical Executive. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Pharmaceutical Executive?

Recent guests on Pharmaceutical Executive include:

1. Natalie de Graaf
2. Peter Harbin
3. Jeff Golfman
4. Maher Masoud
5. Michael Grosberg
6. Jesse Mendelson
7. Deepak Prakash
8. Matt Holms

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days